119 related articles for article (PubMed ID: 11257780)
21. The presence of large lymph node metastasis as a prognostic factor of papillary thyroid carcinoma.
Kitajiri S; Hiraumi H; Hirose T; Hosaka N
Auris Nasus Larynx; 2003 May; 30(2):169-74. PubMed ID: 12753989
[TBL] [Abstract][Full Text] [Related]
22. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
23. Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece.
Tzavara I; Vlassopoulou B; Alevizaki C; Koukoulis G; Tzanela M; Koumoussi P; Sotsiou F; Thalassinos N
Clin Endocrinol (Oxf); 1999 May; 50(5):643-54. PubMed ID: 10468931
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
[TBL] [Abstract][Full Text] [Related]
26. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
27. Impact of extensive neck dissection on survival from papillary thyroid cancer.
Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
[TBL] [Abstract][Full Text] [Related]
28. Survival of differentiated thyroid carcinoma studied in 500 patients.
Lerch H; Schober O; Kuwert T; Saur HB
J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
[TBL] [Abstract][Full Text] [Related]
29. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
Akslen LA; Varhaug JE
Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
Leboulleux S; Rubino C; Baudin E; Caillou B; Hartl DM; Bidart JM; Travagli JP; Schlumberger M
J Clin Endocrinol Metab; 2005 Oct; 90(10):5723-9. PubMed ID: 16030160
[TBL] [Abstract][Full Text] [Related]
31. Do the prognoses of papillary and follicular thyroid carcinomas differ?
Donohue JH; Goldfien SD; Miller TR; Abele JS; Clark OH
Am J Surg; 1984 Jul; 148(1):168-73. PubMed ID: 6742325
[TBL] [Abstract][Full Text] [Related]
32. [Prognostically relevant factors in follicular thyroid cancer].
Böttger T; Klupp J; Sorger K; Junginger T
Langenbecks Arch Chir; 1990; 375(5):266-71. PubMed ID: 2259260
[TBL] [Abstract][Full Text] [Related]
33. Survival and prognostic factors in thyroid carcinoma.
Joensuu H; Klemi PJ; Paul R; Tuominen J
Acta Radiol Oncol; 1986; 25(4-6):243-8. PubMed ID: 3030051
[TBL] [Abstract][Full Text] [Related]
34. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
35. Thyroid carcinoma: a clinical and pathologic study of 125 cases.
Frauenhoffer CM; Patchefsky AS; Cobanoglu A
Cancer; 1979 Jun; 43(6):2414-21. PubMed ID: 455228
[TBL] [Abstract][Full Text] [Related]
36. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
37. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
38. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes.
Mizukami Y; Noguchi M; Michigishi T; Nonomura A; Hashimoto T; Otakes S; Nakamura S; Matsubara F
Histopathology; 1992 Mar; 20(3):243-50. PubMed ID: 1563711
[TBL] [Abstract][Full Text] [Related]
40. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid.
Ohshima A; Yamashita H; Noguchi S; Uchino S; Watanabe S; Toda M; Koike E; Takatu K; Yamashita H
Arch Surg; 2000 Oct; 135(10):1194-8; discussion 1199. PubMed ID: 11030879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
